Clin J Oncol Nurs. 2026 Sep 30;30(5):E87-E96. doi: 10.1188/26.CJON.E87-E96.
ABSTRACT
Advances in therapy have transformed multiple myeloma (MM) into a chronic relapsing-remitting disease, resulting in a growing population of survivors requiring long-term, comprehensive care. Five-year relative survival for.
PMID:42832323 | DOI:10.1188/26.CJON.E87-E96